To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334
Status:
Completed
Trial end date:
2007-10-04
Target enrollment:
Participant gender:
Summary
GSK618334 is being developed as an innovative treatment for substance dependence and
potentially other compulsive behavioral disorders. This study will evaluate the safety,
tolerability and pharmacokinetics of single doses of GSK618334 in healthy volunteers.